Vimarsana
Biggest News Aggregation in the World

Howardc Herrmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Howardc Herrmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Howardc Herrmann Today - Breaking & Trending Today

Medtronic has more positive transcatheter heart valve data - Vimarsana News

Medtronic has more positive transcatheter heart valve data

Medtronic (NYSE: MDT) today announced the release of new data for its transcatheter heart valve therapy technologies.

For Small Annuli, Self-Expanding TAVR May Have an Advantage - Vimarsana News

For Small Annuli, Self-Expanding TAVR May Have an Advantage

A head-to-head trial of two widely used TAVR devices in patients with small aortic annuli, mostly women, showed differences in performance at 1 year in the SMART trial.

Self-Expanding Valve Outperforms Balloon-Expandable Valve for TAVR in Patients with Small Valve Annulus - Vimarsana News

Self-Expanding Valve Outperforms Balloon-Expandable Valve for TAVR in Patients with Small Valve Annulus

First head-to-head comparison of leading valve types finds better valve performance with selfexpanding valve and non-inferior clinical outcomes at one year

SMART trial shows comparable outcomes of two common TAVR devices in small aortic annulus patients - Vimarsana News

SMART trial shows comparable outcomes of two common TAVR devices in small aortic annulus patients

People with a small aortic annulus, a part of the heart's anatomy where the left ventricle meets the aorta, who underwent transcatheter aortic valve replacement (TAVR) with a supra-annular self-expanding valve saw similar clinical outcomes and superior valve performance at one year compared with those who underwent TAVR with a balloon-expandable valve, according to research presented at the American College of Cardiology's Annual Scientific Session.

SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women - Vimarsana News

SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women

New data from largest head-to-head randomized control TAVR trial demonstrates non-inferior clinical outcomes and superior valve performance for Evolut TAVR compared to Sapien™ at one year DUBLIN...